BECTON DICKINSON & CO (BDX)

As of 31 August 2026, short interest in BDX is 10,672,859 shares, up 657,636 shares over the last month. Over the last 48 readings it ranged from 1,895,383 shares (29 November 2024) to 14,558,496 shares (13 February 2026). At the reported average volume of 1.7M shares a day that is 6.1 days to cover, elevated.

<iframe src="https://xoomar.com/embed/stocks/bdx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

As of 17 September 2026, the short share of BDX volume is 56.3%, up 6.6 points over the last five sessions. Over the last 52 readings it ranged from 36.5% (9 July 2026) to 84.9% (14 July 2026). The latest reading is in line with the 30-session average of 58.2%, on 674K shares reported.

As of 28 August 2026, the fails-to-deliver balance in BDX is 1,560 shares, up 1,554 shares over the last settlement date. Over the last 52 readings it ranged from 2 shares (23 March 2026) to 299,911 shares (8 May 2026). The latest reading sits at the bottom of that range.

Insiders at BDX reported 6 open-market sells worth $1.4M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Roque Vitor (EVP & Chief Financial Officer) on 2026-09-02.

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.

24 Form 144 notices on file for BDX worth $7.6M at the prices reported; 7 in the last 90 days worth $1.5M. Latest: MICHAEL FELD filed on 2026-08-26 to sell 165 shares ($31K) from 2026-08-26.

6 holders above 5% have filed on BDX, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 7.5% of the class (21,397,756 shares), filed 2026-04-29 for an event on 2026-03-31.

6 of the 30 tracked managers held BDX at their latest 13F, $188.9M in total at quarter-end prices. AQR Capital Management is the largest at $98.1M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 4 cut.

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

In Q2 2026 (quarter ended 2026-06-30) BECTON DICKINSON & CO reported revenue of $4.98B, up 5.4% from the same quarter a year earlier, and net income of $377.0M (1.37 diluted EPS). In FY 2025 it reported and spent $1.00B on buybacks and $1.20B on dividends. As of 2026-06-30, cash was $708.0M against $16.81B of debt.

Quarterly, last 8 quarters

Fiscal years, with buybacks and dividends

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-06-30 from the cover page.

6 contract actions on file for BDX: $2.2M obligated in the last 90 days and $2.2M in the last 12 months across 3 awarding agencies. The largest was $561K from the Department of Health and Human Services on 2026-07-10 (bd facsdiscover s8 cell sorter). Only actions large enough to reach the daily top list are counted, and agencies report with a lag.